IFP Advisors’s Trulieve Cannabis Corp TRLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-616
Closed -$16K 4699
2021
Q4
$16K Sell
616
-64
-9% -$1.66K ﹤0.01% 2055
2021
Q3
$18K Hold
680
﹤0.01% 2039
2021
Q2
$26K Sell
680
-275
-29% -$10.5K ﹤0.01% 1820
2021
Q1
$45K Buy
955
+504
+112% +$23.7K ﹤0.01% 1518
2020
Q4
$14K Buy
451
+112
+33% +$3.48K ﹤0.01% 1943
2020
Q3
$7K Hold
339
﹤0.01% 2068
2020
Q2
$4K Buy
339
+100
+42% +$1.18K ﹤0.01% 2219
2020
Q1
$2K Buy
239
+155
+185% +$1.3K ﹤0.01% 2439
2019
Q4
$1K Buy
+84
New +$1K ﹤0.01% 2789
2019
Q1
$4K Buy
+300
New +$4K ﹤0.01% 1972

Other funds holding TRLV

IFP Advisors's TRLV Position: Q1 2022 in Review

IFP Advisors sold out of Trulieve Cannabis Corp (TRLV) in Q1 2022, closing a stake of 616 shares — an estimated $16K sold.

IFP Advisors first reported a position in TRLV in Q1 2019 and held it in 10 quarters. The position peaked at $45K in Q1 2021. 14 funds tracked by Wall St. Rank hold TRLV as of Q1 2022.

  • IFP Advisors reported no remaining Trulieve Cannabis Corp position as of Q1 2022 after selling out during the quarter.
  • IFP Advisors sold 616 Trulieve Cannabis Corp shares in Q1 2022, an estimated $16K.
  • IFP Advisors first reported a position in Trulieve Cannabis Corp in Q1 2019 and held it in 10 quarters.
  • IFP Advisors's Trulieve Cannabis Corp position peaked at $45K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q1 2022.

Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.